title: Development of bullous pemphigoid during nivolumab therapy.
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: William
authors.initials: W
authors.lastname: Damsky
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Lauren
authors.initials: L
authors.lastname: Kole
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Mary M
authors.initials: MM
authors.lastname: Tomayko
keywords: BP, bullous pemphigoid; Bregs, B regulatory cells; CTLA-4, cytotoxic T-lymphocyte–associated protein 4; IRAE, immune-related adverse events; PD-1, programmed cell death protein 1; PD-L1, programmed death ligand 1; bullous pemphigoid; nivolumab; pembrolizumab; programmed cell death protein 1; programmed cell death protein 1 inhibitor